Jubilant Life Sciences is currently trading at Rs. 812.05, up by 9.45 points or 1.18% from its previous closing of Rs. 802.60 on the BSE.
The scrip opened at Rs. 802.00 and has touched a high and low of Rs. 820.75 and Rs. 796.40 respectively. So far 25123 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 1 has touched a 52 week high of Rs. 909.75 on 04-Aug-2020 and a 52 week low of Rs. 230.00 on 25-Mar-2020.
Last one week high and low of the scrip stood at Rs. 843.95 and Rs. 790.05 respectively. The current market cap of the company is Rs. 12958.32 crore.
The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 28.53% and 20.79% respectively.
Jubilant Life Sciences has issued Commercial Papers (CPs) of Rs 50 crore on August 18, 2020. Date of maturity of the said commercial papers is September 29, 2020. The aggregate amount of commercial papers (including this issue) outstanding as on date is Rs 200 crore.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
